Top 40 Life Science Startup Investors in Australia (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Tin Alley Ventures
VC Fund
|
3 | Australia, Philippines, United States | Pre-Seed, Seed, Series B | Biotechnology, Life Science, Pharmaceutical | $430k–$20M |
|
Main Sequence Ventures
VC Fund
|
3 | Australia, United States, Philippines | Seed, Series A, Series B | Artificial Intelligence, Software, Information Technology | $1M–$72M |
|
Catalio Capital Management
VC Fund
|
2 | United States, Israel, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9.7M–$208M |
|
Harry Debney
Angel
|
1 | Australia | Series A | Life Science, Biotechnology, Venture Capital | |
|
Riverlane Capital
VC Fund
|
1 | Australia | Series A | Life Science, Biotechnology, Venture Capital | |
|
Annie Hill
Angel
|
1 | Australia | Seed | Aquaculture, Life Science, Biotechnology | |
|
Swinburne Ventures
VC Fund
|
1 | Australia | Venture - Series Unknown | Health Care, Life Science, Biotechnology | |
|
Herzberg Family Office
VC Fund
|
1 | Australia | Seed | Biopharma, Life Science, Therapeutics | |
|
Fantail Ventures
VC Fund
|
1 | United States, Australia, New Zealand | Seed, Venture - Series Unknown, Series A | Software, FinTech, Financial Services | $500k–$19M |
|
Melbourne Angels
VC Fund
|
1 | Australia, New Zealand, United States | Seed, Angel | Software, Information Technology, Biotechnology | $34k–$1.5M |
|
Yosemite
VC Fund
|
1 | United States, Australia | Seed, Series A, Series B | Health Care, Biotechnology, Medical | $4.3M–$175M |
|
Possible Ventures
VC Fund
|
1 | Germany, United States, Australia | Seed, Pre-Seed, Series A | Software, Information Technology, Biotechnology | $586k–$47M |
|
Brandon Capital
VC Fund
|
1 | Australia, United Kingdom, United States | Series A, Venture - Series Unknown, Seed | Biotechnology, Health Care, Medical | $673k–$81M |
|
Alium Capital
VC Fund
|
1 | Australia, United States, Hong Kong | Series A, Series B, Seed | Software, Artificial Intelligence, FinTech | $2M–$465M |
|
The March Group
VC Fund
|
1 | United States, Denmark, Australia | Series A, Seed, Series C | Biotechnology, SaaS, AgTech | $4.7M–$33M |
|
HOF Capital
VC Fund
|
1 | United States, United Kingdom, Singapore | Seed, Series A, Series B | Artificial Intelligence, Software, Financial Services | $850k–$863M |
|
ONE Innovators
VC Fund
|
1 | Japan, Australia | Series B, Seed, Series A | AgTech, Sensor, Farming | |
|
Icehouse Ventures
VC Fund
|
1 | New Zealand, United States, Australia | Seed, Series A, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $485k–$20M |
|
Uniseed
VC Fund
|
1 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Manufacturing, Health Care | $566k–$22M |
|
Accelerating Commercialisation - AusIndustry
VC Fund
|
1 | Australia | Grant, Pre-Seed | Software, SaaS, Health Care | $200k–$590k |
|
Paul Little’s family office
VC Fund
|
1 | Australia | Seed, Series A | E-Commerce, Real Estate, Life Science | |
|
AbbVie Biotech Ventures
VC Fund
|
1 | United States, China, Italy | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6M–$115M |
|
AbbVie
VC Fund
|
1 | United States, United Kingdom, China | Series A, Grant, Seed | Biotechnology, Health Care, Medical | $3.5M–$81M |
|
Churchill Asset Management
VC Fund
|
1 | United States, Canada, Australia | Debt Financing, Private Equity, Series A | Health Care, Manufacturing, Food and Beverage | |
|
Uniseed Ventures
VC Fund
|
1 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Manufacturing | $381k–$94M |
|
Bioplatforms Australia
VC Fund
|
1 | Australia | Pre-Seed | AgTech, Farming, Agriculture | |
|
Digitalis Ventures
VC Fund
|
1 | United States, United Kingdom, China | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $1.5M–$150M |
|
OneVentures
VC Fund
|
1 | Australia, United States, Israel | Series A, Debt Financing, Venture - Series Unknown | Software, Health Care, SaaS | $1.2M–$35M |
|
Medical Research Commercialisation Fund (MRCF)
VC Fund
|
1 | Australia, United States, United Kingdom | Series A, Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $1.3M–$35M |
|
Breakthrough Victoria
VC Fund
|
1 | Australia, United States, Philippines | Seed, Venture - Series Unknown, Series A | Health Care, Manufacturing, Biotechnology | $500k–$35M |
|
Artesian VC
VC Fund
|
1 | Australia, United States, China | Seed, Venture - Series Unknown, Pre-Seed | Software, Health Care, Artificial Intelligence | $40k–$17M |
|
Parkview International
VC Fund
|
1 | Australia, United States | Series A, Series C | Pet, Medical, Veterinary | |
|
Third Hemisphere
VC Fund
|
1 | Australia | Seed | Aquaculture, Life Science, Biotechnology | |
|
Skalata
VC Fund
|
1 | Australia, United States, United Kingdom | Pre-Seed, Seed | Software, Artificial Intelligence, Information Technology | $129k–$2.3M |
|
Time Ventures
VC Fund
|
1 | United States, Germany, Australia | Series A, Series B, Seed | Software, Artificial Intelligence, Sustainability | $3.1M–$450M |
|
Alberici
VC Fund
|
1 | Australia | Seed | Real Estate, Life Science, Property Management | |
|
Dennis Mehiel
Angel
|
1 | Australia | Series A | Life Science, Biotechnology, Venture Capital | |
|
Benny Kleist
Angel
|
1 | Australia, New Zealand | Pre-Seed, Series A | Education, E-Learning, Life Science | |
|
Antler
VC Fund
|
1 | United States, Singapore, Australia | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
Flintco, LLC
VC Fund
|
1 | Australia | Seed | Real Estate, Life Science, Property Management | |
| Access all 69 investors in Australia Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Our primary focus is on spinouts built upon research intellectual property, however we can also invest in existing companies if the link to the University of Melbourne is strong. We lead rounds and can invest from A$500,000 up to A$5m.
Show more...Investment focus
- Industry: Biotechnology, Life Science, Pharmaceutical
- Stage:Pre-Seed, Seed, Series B
- Geography: Australia, Philippines, United States
Investor stats
- Total investments: 9
- Round size: Seed $2.9M–$20M; Pre-Seed $430k–$2.9M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Twin1 AI — Twin1 is a privacy-first platform that gives every professional an AI-powered digital twin to scale their expertise.
- Skopos Bio — Skopos Bio is an Australian biotechnology company developing targeted radiopharmaceutical therapies for cancer treatment.
- Kronus — Kronus compiles engineering intent into software, tests, and assurance evidence; traceably and deterministically.
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 138
- Round size: Seed $1M–$7M; Series A $4.8M–$35M; Series B $14M–$72M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $305M in 2023
Portfolio highlights
- Diraq — Diraq is building quantum computers using modified silicon transistors, the technology best suited to reaching utility scale, where value outweighs cost.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, Switzerland
Investor stats
- Total investments: 151
- Round size: Series A $9.7M–$150M; Series B $26M–$130M; Series C $70M–$208M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely actively investing — fresh fund, raised $16M in 2026
Portfolio highlights
- OSPRI — OSPRI is updating the infectious illness testing plan. Established by the combination of Community Direct DX, Scienetix, and the R&D section of Advanta Genetics, OSPRI is among the first molecular testing platforms in the world to be entirely vertically integrated.
- BigHat Biosciences — We use machine learning and synthetic biology to design and engineer antibody therapeutics.
- Enveda Biosciences — Enveda exists to give hope to millions of people around the world by accelerating the discovery of better medicines.
CEO @ Costa Group
Show more...Investment focus
- Industry: Life Science, Biotechnology, Venture Capital
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
Long-term owner-operators of great Australian businesses.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Venture Capital
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
Annie Hill
Show more...Investment focus
- Industry: Aquaculture, Life Science, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Fremantle Seaweed — Fremantle Seaweed is committed to combating climate change by growing Asparagopsis along with a variety of other local seaweeds ocean grown in local Western Australia waters.
Swinburne Ventures operates as a venture capital firm. Swinburne Ventures the venture capital arm of Swinburne University of Technology.
Show more...Investment focus
- Industry: Health Care, Life Science, Biotechnology
- Stage:Venture - Series Unknown
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Eudaemon Technologies — The first hydrogel condom. A revolution in intimacy.
Family Office
Show more...Investment focus
- Industry: Biopharma, Life Science, Therapeutics
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Mucpharm — Clinical stage bio-pharma company focused on the treatment of mucin-containing and secreting cancers. Bromelain and acetylcysteine, BromAc™, is a patented combination drug developed by our team for mucinous cancers, where the drug affects glycosidic linkages and disulphide bonds in glycoproteins including mucinous tumours. Bromelain is an enzymeextracted from pineapple stem or fruit (ananas comosus) and it is made up of a number of enzymes (proteases, carbohydrases, phosphatases, peroxidases, etc.) that gives it unique enzymatic properties for the hydrolysis of glycosidic bonds in complex carbohydrates. As a therapeutic molecule, it is currently used as a mucolytic in combination with acetylcysteine with anticancer properties for the treatment of mucinous tumours. It combines synergistically with a variety of anticancer drugs.
Fantail Ventures invests in and advises early-stage companies in the fields of data and analytics, digital media, e-commerce, fintech, and wellness.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United States, Australia, New Zealand
Investor stats
- Total investments: 68
- Round size: Seed $1.3M–$4M; Series A $3.5M–$13M; Venture - Series Unknown $500k–$19M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Paxos — Paxos builds regulated blockchain and digital asset solutions for global leaders in financial services. Designed for enterprises.
- Cynamics — Next-generation NDR solution for threat prediction and response.
- NewStand — New Stand is a rapidly expanding convenience and engagement platform that blends physical touchpoints with digital perks and location-based media to be consistently helpful and engaging in people’s lives.
Melbourne Angels is the most active startup investor in Victoria, one of the most active in Australia. Investing in start-ups since 2007, Melbourne Angels is committed to helping innovative founders build the next generation of our economy.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Angel
- Geography: Australia, New Zealand, United States
Investor stats
- Total investments: 73
- Round size: Seed $34k–$1.5M; Angel $200k–$918k
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Emanda — Thinking about selling your business in Australia? Emanda guides you through every step: business valuation, health check, corporate compliance, and sale process. Start with a business valuation.
- Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
- Bitwise Agronomy — Bitwise Agronomy uses AI to analyze crop video footage and provide growers with insights into crop health, growth, and yield potential.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Yosemite supports the development of technologies and treatments intended to reduce cancer mortality. The company collaborates with researchers, scientists, and entrepreneurs working across the oncology sector, aiming to accelerate progress in diagnostics, therapies, and care delivery. Yosemite funds projects ranging from early-stage nonprofit initiatives to later-stage companies, providing capital across the full spectrum of cancer innovation. Its investment approach is structured to catalyze breakthroughs that contribute to making cancer a manageable and non-lethal condition. Yosemite's portfolio spans various domains of cancer research and treatment, including targeted therapies, immuno-oncology, early detection, and patient-centric solutions.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, Australia
Investor stats
- Total investments: 20
- Round size: Seed $4.3M–$86M; Series A $20M–$120M; Series B $30M–$175M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Skopos Bio — Skopos Bio is an Australian biotechnology company developing targeted radiopharmaceutical therapies for cancer treatment.
- HistoSonics — HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.
- Chai Discovery — Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United States, Australia
Investor stats
- Total investments: 173
- Round size: Seed $1.5M–$10M; Pre-Seed $586k–$3.5M; Series A $9.7M–$47M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Mkind — Mkind builds intelligent robots for high-mix manufacturing, developing advanced automation solutions that can adapt to diverse production requirements, improve operational efficiency, and support manufacturers in handling complex, low-volume, and frequently changing product lines.
- Reverion — Reverion develops reversible and carbon-negative power plants using patented biogas technology for renewable energy.
- Orbem — Transform biological imaging with AI-powered MRI technology. Non-invasive solutions for poultry, fruits, nuts, and health. Building a sustainable future.
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 84
- Round size: Seed $673k–$9.7M; Series A $5.2M–$81M; Venture - Series Unknown $5.2M–$24M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fresh fund, raised $290M in 2025
Portfolio highlights
- Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
- Lumonus — Lumonous is a healthcare company that offers Radiation Oncology, Radiation Therapy, and Cancer treatment technology-enabled services.
- OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
Alium Capital focuses on listed and unlisted technology investments to generate out-sized returns. The company invests in technology, innovation, and early-stage businesses, all the way through to publicly listed assets. It specializes in the fields of finance, investing, innovation, and capital.Alium Capital was founded in 2016 andheadquartered in Sydney, New South Wales.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Series A, Series B, Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 50
- Round size: Seed $2.2M–$10M; Series A $2M–$11M; Series B $2M–$465M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $79M in 2017
Portfolio highlights
- Boost Lab — Boost Lab provides solutions for skincare products that are cost-effective, effective, and safe.
- Koala — We're simplifying the mattress and furniture game. With free & fast delivery and a 120 night risk-free trial Australia-wide, try it out online today.
- York Street Brands — York Street Brands, formed by the merger of Boost Lab and tbh Skincare specializes in serums that target a range of skin concerns.
A venture capital fund platform committed to supporting and investing in entrepreneurs and companies developing and bringing exponential technologies to food, health and sustainability. March's investment strategy involves becoming recognized as the leading investor in critical and transformative technology solutions, and aims to achieve thisby investing into companies and funds that focus on developing core intellectual property around game-changing sustainable solutions that are aligned with globally relevant sustainability trends and benefits.
Show more...Investment focus
- Industry: Biotechnology, SaaS, AgTech
- Stage:Series A, Seed, Series C
- Geography: United States, Denmark, Australia
Investor stats
- Total investments: 7
- Round size: Seed $4.7M–$4.8M; Series A $7.2M–$33M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fresh fund, raised $5.5M in 2026
Portfolio highlights
- Digestiva — We amplifye Protein.
- EvodiaBio — EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries. Founded in 2021 and is based in Copenhagen, Capital Region.
- Number 8 bio — Number 8 Bio is a scientist-led start-up in Sydney that makes scalable and affordable enteric methane mitigation feed additives for livestock. We have a unique approach to managing rumen energy flows and animal productivity when methane is decreased, and we aim to give farmers a healthy ROI when using the additives.
HOF Capital is a global technology investment firm that leverages its global limited partner network to help founders build massive businesses.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Singapore
Investor stats
- Total investments: 238
- Round size: Seed $850k–$14M; Series A $10M–$40M; Series B $20M–$863M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Solea — Solea is the AI CSR that helps with booking, routing, and logging home service jobs in real time.
- Valar Atomics — Valar Atomics is scaling nuclear energy for heavy industrial power and clean hydrocarbon fuel production.
- Cognition — Cognition develops artificial intelligence systems for software engineering and code automation. The company operates Devin, an AI software engineer that plans, writes, tests, debugs, and deploys code through integrated development workflows. Its platform works with existing development tools and codebases to support engineering tasks acrossapplication development, maintenance, and issue resolution. Cognition also provides tools that assist teams with system design, technical workflows, and collaborative coding processes. The company focuses on AI agents that automate repetitive engineering work while supporting software teams in managing complex development tasks.
The global imperative of achieving net-zero emissions by 2050 demands innovative solutions across all nations, including Japan. Recognizing this urgency, ONE Innovators has established a dedicated venture capital fund focused on the carbon-neutral sector.
Show more...Investment focus
- Industry: AgTech, Sensor, Farming
- Stage:Series B, Seed, Series A
- Geography: Japan, Australia
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Archeda — Archeda is an IT firm that analysis of natural environments using remote sensing data.
- Creattura — Creatura assists companies in reducing greenhouse gas emissions by generating and distributing carbon credits and promoting the adoption of renewable energy sources.
- Number 8 bio — Number 8 Bio is a scientist-led start-up in Sydney that makes scalable and affordable enteric methane mitigation feed additives for livestock. We have a unique approach to managing rumen energy flows and animal productivity when methane is decreased, and we aim to give farmers a healthy ROI when using the additives.
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 279
- Round size: Seed $643k–$4.9M; Series A $2.5M–$20M; Venture - Series Unknown $485k–$19M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — raised $318k in 2023
Portfolio highlights
- Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
- Vessev — Electric hydrofoiling vessels built for commercial use. Quiet, efficient, and better for the world.
- First Table — Book the first table of the night and you'll get 50% off the food bill for two to four people!
Uniseed is Australia's first, and longest running, university owned venture fund. Established in 2000, we are owned by 9 universities plus CSIRO (behind over 60% of Australia's research) and fund deep-tech spinouts through to global scale.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Health Care
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 94
- Round size: Seed $670k–$3.5M; Series A $1.6M–$16M; Series B $566k–$22M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — raised $15M in 2017
Portfolio highlights
- DeteQt — Semiconductor chip-based quantum magnetic field sensors using diamond - navigation, mining, medical imaging
- R2Crete — R2Crete is an engineering startup developing a process to recycle waste concrete into supplementary cementitious material (SCM) and high-quality aggregates for new concrete production. As cement is the most emissions-intensive component of concrete production, every tonne replaced by SCM directly reduces carbon impact. R2Crete's eco-friendly supplementary cementitious material (SCM) and aggregates are high performance, cost-competitive and can provide significant environmental benefits.
- Facet Amtech — Facet Amtech develops and produces ammonia from water and air.
A grant program offered by AusIndustry as part of the Australian Government’s National Innovation and Science Agenda
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Grant, Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 13
- Round size: Grant $200k–$590k
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Getmee — Getmee AI delivers hyper-personalised coaching for interview readiness, communication skills, and job placement, trusted by 50,000+ users across 15+ countries. Book a demo today.
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Hearables 3D — Scale your custom-fit volumes and solve dental lab technician shortage with AI and automation solutions.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Paul Little’s family office operates as an investment firm.
Show more...Investment focus
- Industry: E-Commerce, Real Estate, Life Science
- Stage:Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
- EstateXchange — Simplest way to settle deceased estates securely. Save time with estates administration. For lawyers, banks & more. Deliver faster outcomes for all.
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Togetherwith its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, China, Italy
Investor stats
- Total investments: 49
- Round size: Series A $6M–$53M; Series B $12M–$83M; Series C $39M–$115M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Mozart Therapeutics — The company intended to focus on developing novel immune engagers.
- Quanta Therapeutics — Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes. The company was founded in 2018 and is based in San Francisco, CA.
- DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Grant, Seed
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 70
- Round size: Seed $4M–$42M; Grant $3.5M–$50M; Series A $7M–$81M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Cloverleaf Bio — Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
- Endlyz Therapeutics — ndLyz Therapeutics, Inc. is developing disease-modifying therapeutics which restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease (PD) and other dementias.
- DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Churchill Asset Management provides private credit and private equity solutions for PE-backed middle market companies across the full capital structure.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Food and Beverage
- Stage:Debt Financing, Private Equity, Series A
- Geography: United States, Canada, Australia
Investor stats
- Total investments: 34
- Lead/follow: 12% lead, 88% follow
- Last fund: Likely actively investing — fresh fund, raised $1.5M in 2026
Portfolio highlights
- US Fertility — US Fertility brings together the brightest minds in reproductive medicine to achieve the highest clinical standards and pregnancy rates in the country. Discover excellence in fertility care today.
- One Physics — Apex Physics Partners serves medical centers and physics practices by offering therapy and diagnostic services and support for medical physics practices.
- Action Behavior Centers — Action Behavior Centers is a center-based provider of ABA therapy for children on the moderate to severe end of the autism spectrum.
Uniseed is Australia's first, and longest running, university owned venture fund. Established in 2000, we are owned by 9 universities plus CSIRO (behind over 60% of Australia's research) and fund deep-tech spinouts through to global scale.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $381k–$4.6M; Series A $1.3M–$16M; Series B $471k–$94M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $14M in 2017
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro's Wi-Fi HaLow combines long-range, strong signal penetration, low power, and high throughput in one wireless protocol, delivering connectivity to more devices, at distance, with greater reliability.
Bioplatforms Australia is a non-profit entity that supports life science research in genomic, proteomics, metabolomics, and bioinformatics.
Show more...Investment focus
- Industry: AgTech, Farming, Agriculture
- Stage:Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Number 8 bio — Number 8 Bio is a scientist-led start-up in Sydney that makes scalable and affordable enteric methane mitigation feed additives for livestock. We have a unique approach to managing rumen energy flows and animal productivity when methane is decreased, and we aim to give farmers a healthy ROI when using the additives.
Engineering solutions to complex problems in health through venture investment and company creation.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 120
- Round size: Seed $1.5M–$15M; Series A $7.5M–$66M; Series B $13M–$150M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — raised $300M in 2023
Portfolio highlights
- Sparkle Grooming Co. — Sparkle is a national wellness-focused dog grooming franchise and pioneer of Quick Service Pet Care (QSPC), a modern approach to routine pet care that combines membership-based services, technology-enabled operations, and a premium salon experience. The company provides recurring grooming and wellness services designed to keep dogs clean, healthy,and happy while helping franchise partners build scalable pet care businesses across the country.
- Enveda Biosciences — Enveda exists to give hope to millions of people around the world by accelerating the discovery of better medicines.
- Matchpoint Therapeutics — Matchpoint aims to discover and develop precision small molecules that harness the power of covalency to bring new possibilities to the treatment of serious immune disease and cancer.
OneVentures is a later-stage venture capital firm focused on scaling Technology and Healthcare companies through growth equity and credit. The firm's role extends far beyond investment, as the firm actively guides companies toward achieving their next critical milestones. By leveraging decades of global experience and operational expertise,OneVentures accelerates growth and helps shape the future of its portfolio companies.A global growth focus drives their investment selection, with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Series A, Debt Financing, Venture - Series Unknown
- Geography: Australia, United States, Israel
Investor stats
- Total investments: 87
- Round size: Series A $1.5M–$23M; Debt Financing $1.2M–$14M; Venture - Series Unknown $3M–$35M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely actively investing — fresh fund, raised $126M in 2025
Portfolio highlights
- me&u — me&u is an online ordering and payment application designed to order meals. They provide communication technology to order and pay through mobile phones at restaurants. Their process of ordering with waiters and splitting bills that enable users to order their food and pay bills through a digital payment platform.
- Truescope — Make better informed communications decisions with Truescope. Harnessing millions of media posts every day to deliver you real-time information that influences your business strategy.
- Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 33
- Round size: Seed $1.3M–$1.7M; Series A $1.3M–$13M; Venture - Series Unknown $4.3M–$35M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- MycRx — MecRx is a drug development company that works on new treatments for cancer and novel mechanism of action antibiotics. Using proprietary “hit identification” technology, MecRx is developing inhibitors of cMyc, a protein that is deregulated in over 50% of all human cancers. MecRx draws on the expertise of the Peter MacCallum Cancer Centre and CSIROand is headquartered in Melbourne, Australia.MecRx was founded in 2013 by an ex-pharma/biotech team. MecRx is run as a virtual company based in Melbourne, Australia and its shareholders and service providers include the Peter MacCallum Cancer Institute and CSIRO. The company secured $5m Series A investment from the MRCF (www.mrcf.com.au) and CSIRO in 2015.
- Currus Biologics — Currus Biologics develops BEAT technology to advance CAR T-cell therapy for solid tumors, aiming to improve treatment outcomes in oncology.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 55
- Round size: Seed $708k–$6.8M; Series A $4M–$35M; Venture - Series Unknown $500k–$30M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- AlleSense — AlleSense has developed a unique and novel solution to label-free imaging, the NanoMslide.
- Mental Jam — We are a games studio dedicated to creating impactful experiences that explore mental health.
- Deftbiotech — Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004, Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Australia, United States, China
Investor stats
- Total investments: 643
- Round size: Seed $40k–$4.2M; Pre-Seed $42k–$553k; Venture - Series Unknown $650k–$17M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $36M in 2023
Portfolio highlights
- Vaulta — Vaulta is a battery casing technology company based in Brisbane, Australia. Using advanced composite materials and smart, streamlined design, Vaulta has developed a lighter and smaller battery case with fewer parts, creating scalable efficiencies and opportunities for manufacturers. Vaulta founder and director Dominic Spooner has over 12 yearsexperience as a design engineer, and has worked in a range of industries, including renewables and batteries, defence and aerospace, consumer products, commercial products and startups. While working in battery design, Dominic saw firsthand that opportunities for growth were being overlooked in favour of continuing with the status quo – and that’s when the idea for Vaulta was born.Vaulta’s world-first no-weld design means modules can be easily assembled and disassembled, cells reused and recycled, and new cells added as battery technology continues to evolve.From stationary storage and electric vehicles to defence, aerospace and beyond, Vaulta’s battery case technology works wherever batteries do.
- TerraBlaster — TerraBlaster is a cutting-edge agricultural technology firm focused on transforming sustainable agriculture through enhanced automation and precise technologies.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Parkview International operates as a single-family office.
Show more...Investment focus
- Industry: Pet, Medical, Veterinary
- Stage:Series A, Series C
- Geography: Australia, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Petfolk — Petfolk's world-class animal hospitals & pet care centers offer virtual, in-person & urgent veterinary care with a pet-parent-focused approach. Learn more!
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
Third Hemisphere is a technology and finance communications firm for innovators and leaders who are breaking new ground.
Show more...Investment focus
- Industry: Aquaculture, Life Science, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Fremantle Seaweed — Fremantle Seaweed is committed to combating climate change by growing Asparagopsis along with a variety of other local seaweeds ocean grown in local Western Australia waters.
Giving Australian founders access to the education, capital and networks needed to build significant, sustainable, global businesses of the future.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 92
- Round size: Seed $135k–$2.3M; Pre-Seed $129k–$406k
- Lead/follow: 80% lead, 20% follow
- Last fund: May invest from a new fund soon — raised $18M in 2021
Portfolio highlights
- Enrola — Looking for online training courses? Discover the perfect course for you with our easy course advisor quiz. Get individual guidance and apply directly.
- Paperly — Paperly is an mobile app that provides modules for school management system and learning management system.
- Cor — Obi by Cor is the leading voice AI agent for customer onboarding and user activation. It uses voice and on-screen awareness to guide users, share best practices, and answer questions in real time.
Time Ventures is an investment fund for Marc Benioff. The company looks to invest in theB2B, hospitality, non-financial services, and commercial products and services sectors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Sustainability
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Australia
Investor stats
- Total investments: 57
- Round size: Seed $3.1M–$450M; Series A $10M–$80M; Series B $20M–$140M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Revoy — We haul Pacific Northwest freight with our 95% electrified fleet.
- June.ai — Discover June, a digital communication hub that replaces your email experience. June creates a new world for your existing email that gives you more control, interactivity and efficiency.
- June — Transform enterprise system deployment with June. AI-driven implementation for Salesforce, Snowflake, SAP & more. No downtime, faster delivery, full control.
Alberici is a diversified construction company recognized for superior quality and customer service. With operations throughout North America and clients around the world, they offer general contracting, construction management, and design-build solutions across a broad spectrum of industrial and commercial markets.
Show more...Investment focus
- Industry: Real Estate, Life Science, Property Management
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- LCG Capital Management — LCG Capital Management is a full-service commercial real estate firm providing integrated solutions across the real estate lifecycle.
Dennis Mehiel is an American entrepreneur and investor, best known as the founder of Box USA. He has held leadership roles across business and public policy organizations and serves on the Board of Directors of the American Security Project.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Venture Capital
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
Benny Kleist is a Founder & COO of Eucalyptus.He attended The University of Queensland.
Show more...Investment focus
- Industry: Education, E-Learning, Life Science
- Stage:Pre-Seed, Series A
- Geography: Australia, New Zealand
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
- NextWork — Building the best online learning experience to switch careers and upskill. Join the waitlist today, we are waiting for you!
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Singapore, Australia
Investor stats
- Total investments: 2387
- Round size: Seed $158k–$4.6M; Pre-Seed $100k–$600k; Series A $4.1M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026
Portfolio highlights
- iiba — Iiba is a geospatial platform that specializes in providing location information related to child-rearing.
- Obud — Obud is a wellness reservation systems that is designed for holistic health and lifestyle management purposes. The company's systems offer a comprehensive suite of tools for booking wellness activities, managing schedules, and accessing curated wellness programs, enabling wellness centers to streamline their operations, enhance userengagement, and promote a balanced and healthy lifestyle.
- Plouton AI —
Flintco provides innovative construction solutions with an unrelenting focus on quality, safety, cost and schedule.
Show more...Investment focus
- Industry: Real Estate, Life Science, Property Management
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LCG Capital Management — LCG Capital Management is a full-service commercial real estate firm providing integrated solutions across the real estate lifecycle.
Life Science Investor funding in Australia at a glance
Stats across 49 deals from 69 investors.
Access all 69 investors in Australia Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in Australia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 69 investors investing in Australia Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!